Requiring covered entities to provide detailed annual reporting on how 340B revenue is used to ensure direct savings for patients, providing a more transparent link between program savings and ...

In a 160-page bill introduced May 11, House Republicans proposed requiring pharmacy benefit managers to adhere to a transparent pass ... covered under the 340B program are excluded.

Finally, the drugmakers outlined several billion dollars in discounted drugs. Over a roughly six-year period, Eli Lilly outlined $7.5 billion in sales at 340B rates that would have reached $16.9 ...